Product Details
Xigduo
Dapagliflozin + Metformin5 mg + 850 mg
Tablet
DIN/PIN/NPN
02449935
Manufacturer
AstraZeneca
Formulary Listing Date
2017-07-31
Unit Price
1.2863
Amount MOH Pays
0.6432
Coverage Status
General Benefit Chronic-Use Medication Insulin or Oral Hypoglycemic Product
ODB Formulary Therapeutic Classification
Therapeutic Note
Dapagliflozin + Metformin 5 mg + 850 mg Tablet: For the treatment of patients with type 2 diabetes mellitus who are already stabilized on therapy with metformin and dapagliflozin, to replace the individual components of dapagliflozin and metformin for those patients who have inadequate glycemic control on metformin, a contraindication or intolerance to a sulfonylurea, and for whom insulin is not an option.
ATC Code
A10BD15
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02449935 | Xigduo | 1.2863 | 0.6432 |
| 02533073 | Auro-Dapagliflozin / Metformin | 0.6432 | 0.6432 |
| 02536153 | Apo-Dapagliflozin-Metformin | 0.6432 | 0.6432 |